433 related articles for article (PubMed ID: 35008657)
1. Novel 1,3,5-Triazinyl Aminobenzenesulfonamides Incorporating Aminoalcohol, Aminochalcone and Aminostilbene Structural Motifs as Potent Anti-VRE Agents, and Carbonic Anhydrases I, II, VII, IX, and XII Inhibitors.
Havránková E; Garaj V; Mascaretti Š; Angeli A; Soldánová Z; Kemka M; Motyčka J; Brázdová M; Csöllei J; Jampílek J; Supuran CT
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008657
[TBL] [Abstract][Full Text] [Related]
2. Novel sulfonamide incorporating piperazine, aminoalcohol and 1,3,5-triazine structural motifs with carbonic anhydrase I, II and IX inhibitory action.
Havránková E; Csöllei J; Vullo D; Garaj V; Pazdera P; Supuran CT
Bioorg Chem; 2018 Apr; 77():25-37. PubMed ID: 29324250
[TBL] [Abstract][Full Text] [Related]
3. Novel 2-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)-1-(1,3,5-triazin-2-ylamino)guanidine derivatives: Inhibition of human carbonic anhydrase cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII, anticancer activity, and molecular modeling studies.
Żołnowska B; Sławiński J; Szafrański K; Angeli A; Supuran CT; Kawiak A; Wieczór M; Zielińska J; Bączek T; Bartoszewska S
Eur J Med Chem; 2018 Jan; 143():1931-1941. PubMed ID: 29146134
[TBL] [Abstract][Full Text] [Related]
4. Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
Żołnowska B; Sławiński J; Pogorzelska A; Chojnacki J; Vullo D; Supuran CT
Eur J Med Chem; 2014 Jan; 71():135-47. PubMed ID: 24291567
[TBL] [Abstract][Full Text] [Related]
5. Discovery of new ureido benzenesulfonamides incorporating 1,3,5-triazine moieties as carbonic anhydrase I, II, IX and XII inhibitors.
Lolak N; Akocak S; Bua S; Sanku RKK; Supuran CT
Bioorg Med Chem; 2019 Apr; 27(8):1588-1594. PubMed ID: 30846402
[TBL] [Abstract][Full Text] [Related]
6. Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX.
Garaj V; Puccetti L; Fasolis G; Winum JY; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
Bioorg Med Chem Lett; 2005 Jun; 15(12):3102-8. PubMed ID: 15905091
[TBL] [Abstract][Full Text] [Related]
7. Novel sulfonamides incorporating 1,3,5-triazine and amino acid structural motifs as inhibitors of the physiological carbonic anhydrase isozymes I, II and IV and tumor-associated isozyme IX.
Mikuš P; Krajčiová D; Mikulová M; Horváth B; Pecher D; Garaj V; Bua S; Angeli A; Supuran CT
Bioorg Chem; 2018 Dec; 81():241-252. PubMed ID: 30153589
[TBL] [Abstract][Full Text] [Related]
8. Carbonic anhydrase inhibitors: synthesis and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associated) and XIV with 4-substituted 3-pyridinesulfonamides.
Brzozowski Z; Sławiński J; Saczewski F; Innocenti A; Supuran CT
Eur J Med Chem; 2010 Jun; 45(6):2396-404. PubMed ID: 20202722
[TBL] [Abstract][Full Text] [Related]
9. S-substituted 2-mercaptoquinazolin-4(3H)-one and 4-ethylbenzensulfonamides act as potent and selective human carbonic anhydrase IX and XII inhibitors.
El-Azab AS; Abdel-Aziz AA; Bua S; Nocentini A; AlSaif NA; Alanazi MM; El-Gendy MA; Ahmed HEA; Supuran CT
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):733-743. PubMed ID: 32189526
[TBL] [Abstract][Full Text] [Related]
10. Substituted benzene sulfonamides incorporating 1,3,5-triazinyl moieties potently inhibit human carbonic anhydrases II, IX and XII.
Saluja AK; Tiwari M; Vullo D; Supuran CT
Bioorg Med Chem Lett; 2014 Mar; 24(5):1310-4. PubMed ID: 24507918
[TBL] [Abstract][Full Text] [Related]
11. Sulfonamide bearing pyrazolylpyrazolines as potent inhibitors of carbonic anhydrase isoforms I, II, IX and XII.
Khloya P; Ceruso M; Ram S; Supuran CT; Sharma PK
Bioorg Med Chem Lett; 2015 Aug; 25(16):3208-12. PubMed ID: 26105196
[TBL] [Abstract][Full Text] [Related]
12. New anthranilic acid-incorporating N-benzenesulfonamidophthalimides as potent inhibitors of carbonic anhydrases I, II, IX, and XII: Synthesis, in vitro testing, and in silico assessment.
El-Azab AS; Abdel-Aziz AA; Bua S; Nocentini A; AlSaif NA; Almehizia AA; Alanazi MM; Hefnawy MM; Supuran CT
Eur J Med Chem; 2019 Nov; 181():111573. PubMed ID: 31394463
[TBL] [Abstract][Full Text] [Related]
13. Discovery of curcumin inspired sulfonamide derivatives as a new class of carbonic anhydrase isoforms I, II, IX, and XII inhibitors.
Ramya PVS; Angapelly S; Angeli A; Digwal CS; Arifuddin M; Babu BN; Supuran CT; Kamal A
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1274-1281. PubMed ID: 28965419
[TBL] [Abstract][Full Text] [Related]
14. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties.
Garaj V; Puccetti L; Fasolis G; Winum JY; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
Bioorg Med Chem Lett; 2004 Nov; 14(21):5427-33. PubMed ID: 15454239
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and Inhibition Activity Study of Triazinyl-Substituted Amino(alkyl)-benzenesulfonamide Conjugates with Polar and Hydrophobic Amino Acids as Inhibitors of Human Carbonic Anhydrases I, II, IV, IX, and XII.
Mikulová MB; Kružlicová D; Pecher D; Petreni A; Supuran CT; Mikuš P
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681940
[TBL] [Abstract][Full Text] [Related]
16. Discovery of novel benzenesulfonamides incorporating 1,2,3-triazole scaffold as carbonic anhydrase I, II, IX, and XII inhibitors.
Buza A; Türkeş C; Arslan M; Demir Y; Dincer B; Nixha AR; Beydemir Ş
Int J Biol Macromol; 2023 Jun; 239():124232. PubMed ID: 37001773
[TBL] [Abstract][Full Text] [Related]
17. Anticancer effects of new dibenzenesulfonamides by inducing apoptosis and autophagy pathways and their carbonic anhydrase inhibitory effects on hCA I, hCA II, hCA IX, hCA XII isoenzymes.
Gul HI; Yamali C; Bulbuller M; Kirmizibayrak PB; Gul M; Angeli A; Bua S; Supuran CT
Bioorg Chem; 2018 Aug; 78():290-297. PubMed ID: 29621641
[TBL] [Abstract][Full Text] [Related]
18. Discovery of potent anti-convulsant carbonic anhydrase inhibitors: Design, synthesis, in vitro and in vivo appraisal.
Mishra CB; Kumari S; Angeli A; Bua S; Buonanno M; Monti SM; Tiwari M; Supuran CT
Eur J Med Chem; 2018 Aug; 156():430-443. PubMed ID: 30015076
[TBL] [Abstract][Full Text] [Related]
19. Novel 2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide based thiosemicarbazides as potent and selective inhibitors of tumor-associated human carbonic anhydrase IX and XII: Synthesis, cytotoxicity, and molecular modelling studies.
Demir-Yazıcı K; Trawally M; Bua S; Öztürk-Civelek D; Akdemir A; Supuran CT; Güzel-Akdemir Ö
Bioorg Chem; 2024 Mar; 144():107096. PubMed ID: 38290186
[TBL] [Abstract][Full Text] [Related]
20. Novel indolin-2-one-based sulfonamides as carbonic anhydrase inhibitors: Synthesis, in vitro biological evaluation against carbonic anhydrases isoforms I, II, IV and VII and molecular docking studies.
Eldehna WM; Al-Ansary GH; Bua S; Nocentini A; Gratteri P; Altoukhy A; Ghabbour H; Ahmed HY; Supuran CT
Eur J Med Chem; 2017 Feb; 127():521-530. PubMed ID: 28109946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
